ISCT 2022: an interview with Jacques Galipeau

We spoke with Jacques Galipeau, President-Elect of the International Society for Cell and Gene Therapy (ISCT; Canada) and Don and Marilyn Anderson Professor in Oncology and Associate Dean for Therapeutics Development at the University of Wisconsin in Madison (WI, USA) about the ISCT 2022 annual meeting. Galipeau discussed the annual meeting and the highlights that can be expected, the challenges of mesenchymal stromal/stem cells (MSCs) and the developments that we can expect to see from the ISCT in the next year. Please introduce yourself and give an overview of your role. I’m a Professor of medicine with a longstanding interest...